A hitchhiker’s guide to cerebrospinal fluid biomarkers for neuro-oncology
Neuro-Oncology · 21.06.2025 · 27 (5) · 1165-1179
DOI: 10.1093/neuonc/noae276 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neuro-Oncology, online erschienen am 30.12.2024. Verfasst von Cecile Riviere-Cazaux und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurological Surgery, Mayo Clinic, Rochester, MN, USA. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Glioma, Brain Neoplasms. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NCI NIH HHS, National Institute of Health.
Abstract (Originalsprache)
Cerebrospinal fluid (CSF) has emerged as a valuable liquid biopsy source for glioma biomarker discovery and validation. CSF produced within the ventricles circulates through the subarachnoid space, where the composition of glioma-derived analytes is influenced by the proximity and anatomical location of sampling relative to tumor, in addition to underlying tumor biology. The substantial gradients observed between lumbar and intracranial CSF compartments for tumor-derived analytes underscore the importance of sampling site selection. Moreover, radiographic features, such as tumor-CSF contact and blood-brain barrier disruption, are critical covariates that may affect biomarker detection and the abundance of plasma-derived analytes in CSF, respectively. Longitudinal intracranial CSF sampling, enabled by access devices like Ommaya reservoirs, may offer a window into treatment response and disease progression, though variability in analyte yield, sample volumes, and the dynamic effects of surgical resection pose challenges. This review critically evaluates the anatomic, radiographic, and longitudinal factors, or “time-space continuum,” that impact glioma CSF biomarker abundance. Practical considerations for longitudinal CSF biobanking, including access device placement and collection, are also reviewed. Key takeaways and recommendations for CSF glioma biomarker discovery and validation are provided as a “hitchhiker’s guide” based on our collective experience, along with resources for investigators aiming to develop CSF biobanking at their institutions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurological Surgery, Mayo Clinic, Rochester, MN, USA.
- Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
- MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada.
- Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
- Department of Neurology and Neuro-oncology Program, Heidelberg University Hospital, Heidelberg, Germany.
- Department of Oncology, Division of Medical Oncology, Mayo Clinic, Rochester, MN, USA.
ORCID-Profile: Cecile Riviere-Cazaux, Mustafa Khasraw, Tobias Kessler, Daniel P Cahill, Alireza Mansouri
Förderung
- NINDS NIH HHS
- NCI NIH HHS
- National Institute of Health
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Riviere-Cazaux, C., Keough, M. B., Zuccato, J. A., Kumar, R., Schulz, S., Warrington, A. E., Ruff, M. W., Ellingson, B. M., Sanai, N., Campian, J. L., Kizilbash, S. H., Parney, I. F., Zadeh, G., Khasraw, M., Kessler, T., Sener, U., Cahill, D. P., Mansouri, A., & Burns, T. C. (2025). A hitchhiker’s guide to cerebrospinal fluid biomarkers for neuro-oncology. Neuro-Oncology, 27(5), 1165-1179. https://doi.org/10.1093/neuonc/noae276
Vancouver
Riviere-Cazaux C, Keough MB, Zuccato JA, Kumar R, Schulz S, Warrington AE, et al. A hitchhiker’s guide to cerebrospinal fluid biomarkers for neuro-oncology. Neuro-Oncology. 2025;27(5):1165-1179. doi:10.1093/neuonc/noae276
BibTeX
@article{RiviereCazaux2025,
author = {Riviere-Cazaux, Cecile and Keough, Michael B and Zuccato, Jeffrey A and Kumar, Rahul and Schulz, Sebastian and Warrington, Arthur E and Ruff, Michael W and Ellingson, Benjamin M and Sanai, Nader and Campian, Jian L and Kizilbash, Sani H and Parney, Ian F and Zadeh, Gelareh and Khasraw, Mustafa and Kessler, Tobias and Sener, Ugur and Cahill, Daniel P and Mansouri, Alireza and Burns, Terry C},
title = {A hitchhiker’s guide to cerebrospinal fluid biomarkers for neuro-oncology},
journal = {Neuro-Oncology},
year = {2025},
volume = {27},
number = {5},
pages = {1165--1179},
doi = {10.1093/neuonc/noae276}
}
EUVIMED